Pila Pharma AB (publ) (STO:PILA)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
TRPV1 Antagonist	1.46M	Log In	Log In	Log In
TRPV1 Antagonist Growth	-22.21%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Sweden	1.46M	Log In	Log In	Log In
Sweden Growth	-22.21%	Log In	Log In	Log In